We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

ACER Acer Therapeutics Inc

0.00 (0.0%)
Dec 07 2023 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 0
Bid Price 0.8702
Ask Price 0.91
News -
Day High


52 Week Range


Day Low
Share Name Share Symbol Market Stock Type
Acer Therapeutics Inc ACER NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.00 0.0% 0.90 18:00:00
Open Price Low Price High Price Close Price Previous Close
0.90 0.90
Trades Shares Traded Average Volume 52 Week Range
0 0 - 0.5515 - 4.56
Last Trade Type Quantity Price Currency
- 0 US$ 0.90 USD

Acer Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
22.02M 24.46M - 0 -26.24M -1.07 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Acer Therapeutics News

Date Time Source News Article
11/08/202315:13Edgar (US Regulatory)Form 425 - Prospectuses and communications, business..
11/08/202315:11Edgar (US Regulatory)Form 8-K - Current report
11/02/202307:51Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting..
11/02/202307:50Edgar (US Regulatory)Form 425 - Prospectuses and communications, business..
11/02/202307:49Edgar (US Regulatory)Form 8-K - Current report
11/02/202307:30GlobeNewswire Inc.Leading Independent Proxy Advisory Firms ISS and Glass Lewis..
10/30/202306:24Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting..
10/10/202316:17Edgar (US Regulatory)Form DEFM14A - Definitive proxy statement relating to merger..
8/31/202308:29Edgar (US Regulatory)Form 425 - Prospectuses and communications, business..
8/31/202308:26Edgar (US Regulatory)Form 8-K - Current report
8/31/202306:30GlobeNewswire Inc.Zevra Therapeutics to Acquire Acer Therapeutics, Expanding..
8/30/202315:05GlobeNewswire Inc.Acer Therapeutics Reacquires Worldwide Development,..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No ACER Message Board. Create One! See More Posts on ACER Message Board See More Message Board Posts

Historical ACER Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.
1 Month0.
3 Months0.8410.920.69050.8247134129,8650.0597.02%
6 Months1.041.75990.55151.221,470,787-0.14-13.46%
1 Year1.604.560.55151.47947,732-0.70-43.75%
3 Years2.595.390.55152.23540,265-1.69-65.25%
5 Years20.0428.24750.55152.70383,956-19.14-95.51%

Acer Therapeutics Description

Acer Therapeutics Inc operates as a pharmaceutical company. Principally, it is focused on the acquisition, development, and commercialization of therapies for patients with serious rare and ultra-rare diseases with a critical unmet medical need. The company's clinical pipeline includes three categories of severe genetic disorders namely EDSIVO for vEDS, and ACER-001 for urea cycle disorders and maple syrup urine disease.

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 |